Open Menu Close Menu

Currently focusing its funding efforts on:
Enabling Drug Screening for Ataxia Telangiectasia. To encourage the discovery of cellular phenotypes and target proteins that are clinically relevant to Ataxia Telangiectasia (A-T) and then to develop assays that can be used to screen for compounds that modulate those phenotypes and targets.